- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Blinatumomab – July 2016
Blinatumomab: Injection 38.5 microgram [1 vial] (&) inert substance solution [10 mL vial], 1 pack, Blincyto®
Last updated
28 October 2016